Best GLP-1 for Seniors: Safest Options, Real Costs, Medicare, and Top Programs

We compared major GLP-1 access paths for adults 60+ — brand-name through your doctor, telehealth programs, and compounded options — focusing on pricing transparency, clinical oversight, senior-specific safety concerns, drug interaction screening, and cancellation terms. Here's what we found.

Quick Decision Guide

What's the Best GLP-1 Medication for Seniors Right Now?

There isn't one best GLP-1 for every senior — and anyone who tells you otherwise is selling something. What there is is a best fit for your situation based on four things: your health conditions, your coverage, your tolerance for injections, and your budget.

Here's how the major GLP-1 medications stack up for adults over 60:

Sources: FDA prescribing information for Wegovy, Ozempic, Zepbound, Mounjaro, Rybelsus. Clinical data from STEP, SURMOUNT, and SELECT trials published in the New England Journal of Medicine.

Which GLP-1 Is Best for YOUR Situation?

I know you didn't come here for a lecture. You came here because something specific is going on — a doctor's recommendation, a friend's transformation, or a number on the scale that's affecting your knees, your blood sugar, or your confidence. So let me cut straight to it.

If You Have Type 2 Diabetes

You're in the strongest position of anyone reading this page. GLP-1 medications were originally designed for type 2 diabetes, and both semaglutide (Ozempic/Rybelsus) and tirzepatide (Mounjaro) are FDA-approved for it. That means:

• Your insurance or Medicare Part D is far more likely to cover it
• You get the dual benefit: better A1C and weight loss
• Your doctor already has a clinical reason to prescribe it

If You Have Heart Disease or High Cardiovascular Risk

This is where the science gets genuinely exciting for older adults. The SELECT trial (published in the New England Journal of Medicine in 2023) studied over 17,600 adults with obesity and established cardiovascular disease. The mean age of participants was 61.6 years. The result: semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) — a composite of cardiovascular death, non-fatal heart attack, and non-fatal stroke — by 20% over a mean follow-up of 39.8 months.

That's not just a weight loss finding. That's a cardiovascular protection finding. And in March 2024, the FDA approved Wegovy specifically for cardiovascular risk reduction in adults with obesity or overweight and established heart disease.

If You're on Medicare or a Fixed Income

Let me be direct about the money, because I know it matters.

What Medicare covers right now (early 2026):

• GLP-1 medications for type 2 diabetes — yes, Medicare Part D covers Ozempic, Mounjaro, and Rybelsus
• GLP-1 medications for cardiovascular risk reduction (Wegovy with the CV indication) — yes, for eligible patients
• GLP-1 medications for weight loss alone — no, not yet

What's changing (CMS BALANCE model): CMS announced a BALANCE model (Medicaid starting May 2026; Medicare Part D starting January 2027) and a separate Medicare GLP-1 Payment Demonstration starting July 2026 that targets a $50/month copay for participating beneficiaries. Availability will depend on whether manufacturers, states, and Part D plan sponsors choose to participate — and CMS will release final eligibility and coverage details as the program develops. This is a significant step forward, but it's not guaranteed universal coverage yet.

Source: CMS BALANCE model announcement (December 23, 2025); NCPA analysis (January 2026).

If you can't wait or don't qualify for Medicare coverage:

Compare all providers side-by-side

For most seniors without insurance coverage, a physician-supervised telehealth program in the $179–$299/month range is the most practical path to GLP-1 access. That's less than many brand-name copays.

Sources: CMS BALANCE model announcement (December 2025); KFF Medicare coverage analysis; AARP Medicare drug coverage guide (February 2026).

If You Want a Pill Instead of a Shot

Good news: you have real options now.

Wegovy tablets received FDA approval in late 2025 and became available in U.S. pharmacies in January 2026. They're approved for the same indications as Wegovy injection — weight management and cardiovascular risk reduction.

Rybelsus (oral semaglutide) has been available for type 2 diabetes since 2019. It's a once-daily tablet that must be taken on an empty stomach with a small sip of water, then you wait at least 30 minutes before eating, drinking, or taking other medications.

MEDVi also offers a compounded oral GLP-1 tablet (daily dissolvable) starting at $249/first month — for those who want the convenience of a pill at a lower cost than brand-name.

If Your Adult Child Is Researching This for You

First — good for them, and good for you. Here's what to look for in a GLP-1 program for your parent:

1. Does the provider screen for drug interactions? Your parent is likely on multiple medications. A provider that doesn't ask about current prescriptions is a red flag.
2. Is there physician-level oversight? Not just a chatbot or algorithm — an actual licensed physician reviewing the case.
3. Can they cancel easily? Seniors (understandably) don't want to feel trapped in a subscription.
4. Is pricing transparent? No hidden fees, no bait-and-switch between intro and refill pricing.

Is GLP-1 Safe for Seniors? What the Clinical Data Actually Shows

This is the question that keeps most seniors on the fence. So let me answer it clearly.

Yes — GLP-1 medications are generally considered safe for adults over 60, and clinical trials have specifically included older adults. The FDA has not set an upper age limit for semaglutide or tirzepatide. In the Wegovy prescribing information, the FDA notes the following geriatric representation across trials:

• Injection weight-management trials: 9% were 65–<75 years old; 1% were 75+
• Tablets weight-management trial: 8% were 65–<75; 2% were 75+
• CV outcomes trial (SELECT): 30% were 65–75; 8% were 75+

No overall differences in safety or efficacy were observed compared to younger adults — though the FDA adds that "increased sensitivity in some geriatric individuals cannot be ruled out." The SELECT trial provides particularly strong evidence because nearly 40% of participants were 65 or older.

Source: Wegovy FDA prescribing information (2024 revision); Lincoff AM et al., "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes," NEJM 2023; 389:2221-2232.

Side Effects Seniors Should Watch For

These are the same side effects that affect all GLP-1 users — but some hit harder when you're older:

Common (and usually manageable):

• Nausea, vomiting, diarrhea — The most frequently reported side effects. Usually worst during the first few weeks and during dose increases. For seniors, the bigger risk is dehydration. Your kidneys don't bounce back as quickly at 67 as they did at 37. Stay ahead of fluids.
• Constipation — Common across all ages. Adequate fiber, hydration, and gentle activity usually help.
• Decreased appetite — This is the mechanism working. But for seniors, eating too little is a real risk. You still need adequate protein and calories even when you're not hungry.

Less common but important:

• Hypoglycemia — Particularly if you're on insulin or sulfonylureas for diabetes. Your provider should adjust your diabetes medications when starting a GLP-1. This is non-negotiable.
• Gallbladder issues — Slightly elevated risk of gallstones, especially with rapid weight loss. Report any severe upper abdominal pain.
• Pancreatitis — Rare but serious. Severe, persistent abdominal pain that radiates to the back needs immediate medical attention.
• Hip and pelvis fractures — In the SELECT cardiovascular outcomes trial, the Wegovy prescribing information notes that patients 75 and older reported more hip and pelvis fractures on Wegovy than placebo. This is important data and one reason why bone health monitoring matters for seniors on GLP-1s.

Sources: FDA prescribing information for Wegovy (2024), Ozempic, Zepbound, Mounjaro; Novo Nordisk novoMEDLINK geriatric safety data. Read our full guide: GLP-1 side effects.

Drug Interactions Seniors Need to Discuss

If you're over 60, there's a decent chance you're taking more than one medication. GLP-1s slow gastric emptying — meaning they change how quickly your stomach processes what you put in it, including other pills. Here's what to flag with your provider:

• Insulin or sulfonylureas: Hypoglycemia risk increases. Your provider should reduce the dose of these medications when starting a GLP-1.
• Blood thinners (warfarin): GLP-1s may affect absorption timing. Your INR should be monitored more closely during the first few months.
• Blood pressure medications: As you lose weight, your blood pressure often drops. You may need less medication, not more. If you get dizzy standing up, tell your doctor.
• Thyroid medication (levothyroxine): Delayed gastric emptying can affect absorption. Maintain your regular dosing routine and get your thyroid levels checked.
• Oral medications taken on an empty stomach: The timing of all oral medications may need review.

This is exactly why I rank providers on drug interaction screening. If a GLP-1 provider doesn't ask what else you're taking during intake, that's not a provider built for seniors. Walk away. For more details, see our safe usage guide.

Is There an Age Limit for GLP-1 Medications?

No. There is no FDA-imposed upper age limit for semaglutide (Wegovy, Ozempic, Rybelsus) or tirzepatide (Zepbound, Mounjaro).

What does matter is your individual health status. Your doctor evaluates kidney function, nutritional status, frailty, current medications, and bone density — not a number on your driver's license. A healthy 72-year-old with obesity and high blood pressure is a completely appropriate candidate. An 85-year-old who's frail and losing weight unintentionally is probably not.

The FDA prescribing information for each medication includes a geriatric use section. For Wegovy, it states that clinical trials included patients 65 and older, and no overall differences in safety or efficacy were observed — but recommends caution in the elderly due to greater frequency of decreased kidney, heart, or liver function and of concomitant disease or medication.

Source: FDA prescribing information, geriatric use sections for Wegovy, Ozempic, Zepbound, Mounjaro.

Will GLP-1 Cause Muscle Loss? A Senior's Guide to Staying Strong

I'm going to be straight with you about something most GLP-1 websites won't touch.

GLP-1 medications can cause muscle loss alongside fat loss. In the STEP trials, roughly 39% of the total weight lost was lean mass (which includes muscle). For a 35-year-old with plenty of muscle to spare, that's a footnote. For a 65-year-old who's already losing muscle naturally — a process called sarcopenia — it matters.

A review published in Pharmacotherapy (2024) on pharmacological treatment of obesity in older adults emphasized that weight-loss interventions in this population should include exercise and adequate protein to preserve muscle and bone. The American Geriatrics Society and AACE/ACE guidelines echo this: evaluate for sarcopenia before and during treatment, and build a preservation plan.

Source: "Pharmacological Treatment of Obesity in Older Adults," PMC (2024); AACE/ACE Obesity Clinical Practice Guidelines. See also: How to prevent muscle loss on GLP-1.

The Senior Muscle Preservation Protocol

This isn't complicated. It just has to be deliberate.

If your GLP-1 provider doesn't discuss protein and exercise with you, they're not treating seniors properly. This is one of the reasons I prioritize physician supervision in my rankings — a good provider builds a preservation plan alongside the prescription.

GLP-1 Provider Comparison for Seniors (2026)

Now let's talk about where to actually get GLP-1 medication if you're 60+. We evaluated providers on what matters most for seniors: medical supervision quality, drug interaction screening, pricing transparency, and how easy it is to cancel if it's not right for you.

Full Provider Comparison Table (Senior-Weighted)

We evaluated each provider using the same rubric — weighted for what matters most when you're 60+.

Pricing verified February 2026 from provider websites. Prices may change; verify on each provider's site before purchasing. Use our cost finder tool or pricing index for the latest.

MEDVi — Best Overall for Seniors Paying Cash

I put MEDVi at the top of this list for a specific reason: it offers the combination of physician supervision, transparent pricing, and clinical support that seniors need — at a price point that doesn't require insurance.

What it costs (verified February 2026):

• First month: $179 (includes physician review, personalized plan, metabolic report, medication, and shipping)
• Monthly refills: $299/month
• Oral tablets: $249/first month (refill pricing varies)
• No contract, no hidden membership fees — month-to-month

What you get:

• Licensed physician review of your health history and current medications (through OpenLoop Health's provider network)
• Compounded semaglutide (weekly injection or daily dissolvable tablet)
• Personalized care plan
• 24/7 support access via unlimited messaging
• Medication shipped to your door (MEDVi states shipping is included in all plans)

Why it works for seniors: The physician-supervised model is what separates MEDVi from bare-bones discount providers. Your health history gets reviewed by a real licensed clinician who decides whether GLP-1 therapy is appropriate for you — and can say no if it isn't. For seniors on multiple medications, this layer of clinical judgment matters.

The honest downside: MEDVi is a cash-pay program. They don't accept insurance or Medicare directly. The intro-to-refill price jump ($179 → $299) is a $120/month increase you should budget for. However — brand-name Wegovy costs $900–$1,500/month at typical cash prices, and even with insurance, many seniors face copays of $300–$500/month. At $299/month for refills, MEDVi is still the more affordable path for most people without full insurance coverage.

What real patients say: One Trustpilot reviewer noted: "The doctors are accessible! Online medication management can feel scary, but they are careful." Another shared a more mixed experience, noting a wait time of about 10 days for an initial appointment — a reminder that telehealth isn't always instant. On ConsumerAffairs, one user reported meaningful weight loss results, going from 158 to 138 pounds, crediting the appetite reduction effect.

Individual results vary. These reviews are shared from third-party platforms (Trustpilot, ConsumerAffairs) to illustrate real patient perspectives, not to guarantee outcomes.

TrimRx — Best Value for Semaglutide (Stable Pricing)

TrimRx stands out for a simple reason: $199/month for compounded semaglutide, all-inclusive, with no price increases as your dose goes up. For seniors who want predictable costs month over month, this matters.

What it costs (verified February 2026):

• Compounded semaglutide: $199/month (all doses)
• Compounded tirzepatide: $349/month (all doses)
• All-inclusive: consultation, medication, supplies, shipping, and follow-up appointments

Why it works for seniors: No membership fee on top of medication cost. The flat pricing means your month-3 cost is the same as your month-1 cost — no surprise jumps. Licensed providers conduct medical evaluations, and the program includes ongoing follow-up appointments. Read our full TrimRx review.

The honest downside: TrimRx is newer to the market compared to some competitors. The level of ongoing support (coaching, community) is lighter than what you'd get with Eden or Willow. If you want a hands-on support experience beyond the prescription, TrimRx is more bare-bones.

Eden — Best Flat Pricing (Same Price at Every Dose)

Eden's signature promise is "same price at every dose" — meaning your monthly cost doesn't increase as your physician adjusts your dosage upward. For seniors on a fixed budget who worry about escalating costs during titration, this is a meaningful differentiator.

What it costs (verified February 2026):

• Compounded semaglutide injection: $149 first month, $249/month ongoing
• Brand-name access (Wegovy, Ozempic, Zepbound, Mounjaro): available but at significantly higher cost
• All plans include: provider consultation, medication, shipping, 24/7 coaching, and community access

Why it works for seniors: Eden provides board-certified physician oversight and has partnered with Gainful for GLP-1-specific nutrition supplements (protein, hydration, gut health). The 24/7 coaching access and community support can help with the lifestyle changes that make GLP-1 therapy work long-term. Available in all 50 states.

The honest downside: Compounded GLP-1 plans require a 3-month prepaid commitment, and filled prescriptions are nonrefundable. Lab testing isn't always required upfront, which means you may not get the same baseline screening that physician-first programs offer. Some reviews mention delayed customer service response times.

Yucca Health — Best Long-Term Plan Pricing

Yucca Health offers some of the lowest per-month pricing in the market — especially on their 6-month plans, where compounded semaglutide drops to approximately $146/month. No membership fee on top of that.

What it costs (verified February 2026):

• Compounded semaglutide: pricing varies by plan length (~$146/mo on 6-month plan; higher on monthly plans)
• Compounded tirzepatide: available (pricing varies)
• No membership fee — medication cost is the total cost
• UPS 2-Day Air shipping included

Why it works for seniors: Yucca's provider review process is thorough — a licensed U.S. physician reviews your intake within 24 hours, and they follow a structured 12-week titration schedule designed to minimize side effects. No video call required for most patients, which can be easier for seniors uncomfortable with telehealth video. Available in all 50 states. Over 20,000 patients reported on their platform.

The honest downside: Yucca is primarily a compounded-medication provider — they don't offer the same brand-name access that Eden does. Customer reviews are generally positive (Trustpilot average around 4.5/5 from 500+ reviews), but newer to market means less long-term track record than established telehealth platforms.

Willow — Premium All-Inclusive Option

Willow is a higher-priced option, but it's truly all-inclusive — $299+/month covers everything: medication, physician-designed treatment plan, same-day prescriptions, free 2-day shipping, and ongoing clinician support through your patient portal.

What it costs (verified February 2026):

• Compounded semaglutide (injection or oral): $299/month
• Compounded tirzepatide: $399+/month
• All-inclusive: no hidden fees, no separate membership charges

Why it works for seniors: Willow's physician team designs personalized treatment plans and offers same-day prescription processing. The patient portal provides direct messaging to your physician. LegitScript-certified for compliance and transparency. Optional ondansetron ($30/mo) for nausea management.

The honest downside: At $299+/month, Willow is the most expensive compounded option on this list. Only available in 33 states — check their site for your state before starting the intake process. Some ConsumerAffairs reviews report mixed experiences with medication effectiveness, though this varies by individual.

The Brand-Name Route: When to Go Through Your Doctor

If any of the following apply to you, telehealth may not be your best first step:

• You have Medicare Part D and type 2 diabetes — Ozempic, Mounjaro, and Rybelsus are covered. Start with your doctor.
• You have cardiovascular disease and obesity — Wegovy may be covered under the cardiovascular indication. Ask your cardiologist.
• You may qualify for the upcoming Medicare GLP-1 Payment Demonstration (July 2026) or BALANCE model (Part D January 2027) — Medicare beneficiaries may access GLP-1s for a $50/month copay once the program launches, depending on manufacturer and plan participation.
• You have complex medical history or 5+ medications — An in-person evaluation with an endocrinologist or obesity medicine specialist gives you a higher level of clinical oversight for the initial assessment. You can always transfer to telehealth for ongoing refills.
• Your private insurance covers brand-name GLP-1s — Some employer plans and Medicare Advantage plans cover Wegovy or Zepbound. Check your formulary first.

I include this section because I'd rather lose an affiliate commission than send you down the wrong path. If brand-name coverage is available to you, use it. Your doctor is still the gold standard for complex cases.

Compounded GLP-1 for Seniors: What You Need to Know

If you're considering a telehealth program like MEDVi that prescribes compounded semaglutide, you should understand what "compounded" means — and what it doesn't.

What compounded semaglutide is: A compounded medication containing semaglutide, prepared by a licensed compounding pharmacy pursuant to a prescription. It is not FDA-approved. These pharmacies are regulated by state boards of pharmacy and, in the case of 503B outsourcing facilities, by the FDA.

What it's not: It is not individually FDA-approved as a finished product. Compounded formulations are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality in the same way it reviews brand-name drugs.

What the FDA has said: The FDA has issued warnings about unapproved GLP-1 drugs used for weight loss and has sent warning letters to companies making misleading claims about compounded semaglutide and tirzepatide. This doesn't mean all compounded semaglutide is unsafe — it means you need to choose your source carefully.

Source: FDA, "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss" (2024); FDA press announcements on warning letters to GLP-1 compounders.

5 Checks Before You Buy Compounded GLP-1 Online

1. Is the pharmacy a licensed 503A or 503B facility? 503B outsourcing facilities are subject to FDA oversight. Ask the provider which pharmacy fills their prescriptions.
2. Is there a licensed prescriber reviewing your case? Not a quiz that auto-generates a prescription — an actual clinician.
3. Is pricing transparent? You should know the first-month cost AND the refill cost before you pay anything.
4. Can you cancel without a fight? Month-to-month with a clear cancellation process is what you want. Avoid programs that lock you into multi-month commitments.
5. Does the provider avoid "guaranteed results" language? Any program promising guaranteed weight loss isn't being medically honest. Results vary.

MEDVi's prescriptions are filled through Belmar Pharma Solutions and Beluga Health, which are U.S.-based pharmacies. Their clinical evaluations are conducted by OpenLoop Health's network of licensed providers who make independent prescribing decisions. Compare options: Best compounded semaglutide | Best compounded tirzepatide.

How Much Weight Do Seniors Lose on GLP-1s?

Let me set realistic expectations.

In the STEP-1 trial, adults taking semaglutide 2.4 mg lost an average of approximately 15% of their body weight over 68 weeks, compared to about 2.4% in the placebo group. The SURMOUNT-1 trial for tirzepatide showed even greater average weight loss — up to 22.5% at the highest dose over 72 weeks. And the SELECT trial showed sustained weight loss averaging 10.2% of body weight over 4 years.

Sources: Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM 2021; Jastreboff AM et al., "Tirzepatide Once Weekly for the Treatment of Obesity," NEJM 2022; SELECT 4-year data presented at ECO 2024. For semaglutide vs tirzepatide details, see our comparison guide.

GLP-1 Dosing for Seniors: What to Expect

All GLP-1 medications use a gradual dose-escalation approach. You don't start at the full dose. This matters for seniors because your body often needs more time to adjust.

Standard semaglutide (injection) titration:

• Weeks 1–4: 0.25 mg/week
• Weeks 5–8: 0.5 mg/week
• Weeks 9–12: 1.0 mg/week
• Weeks 13–16: 1.7 mg/week
• Week 17+: 2.4 mg/week (maintenance)

Source: FDA prescribing information for Wegovy, Ozempic. See also: How to take GLP-1 safely.

What to Expect in Your First 3 Months

Month 1 (Weeks 1–4)

You start at the lowest dose. Most people notice a reduction in appetite within the first week or two. Common experiences: mild nausea (especially after eating rich or fatty foods), some constipation, and a general sense of "I'm just not as hungry."

Typical weight loss: 3–6 pounds in the first month, mostly water and initial fat loss.

Month 2 (Weeks 5–8)

Your dose increases. Appetite reduction becomes more pronounced. Many people report that food just "doesn't call to them" the way it used to — fewer cravings, less snacking, and a genuine feeling of fullness after smaller meals.

Month 3 (Weeks 9–12)

Weight loss becomes more consistent and visible. Blood sugar improvements are often measurable by this point. If you're on blood pressure medication, your numbers may start dropping — which is great, but it means your provider should be monitoring to see if medication doses need adjustment.

When Should a Senior NOT Take GLP-1 Medication?

No medication is right for everyone, and GLP-1s are no exception. I'm including this section because a page that only tells you to buy something isn't a page you should trust. For a detailed list, see our GLP-1 contraindications guide.

Absolute contraindications (do not take):

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Known hypersensitivity to semaglutide or tirzepatide

Situations where GLP-1 may not be appropriate for seniors:

• You're significantly underweight or losing weight unintentionally — adding a weight-loss medication to this situation is dangerous
• You have severe gastroparesis (GLP-1s slow gastric emptying further)
• You have a history of pancreatitis
• You're frail, malnourished, or have advanced sarcopenia
• You have end-stage kidney disease (dosing adjustments and close monitoring are necessary)

This page has still helped you if any of these apply — because now you know what to ask your doctor about.

How GLP-1s Interact with Common Senior Health Conditions

GLP-1 and Type 2 Diabetes

The dual benefit here is undeniable. GLP-1s lower A1C and promote weight loss — both of which are foundational goals for managing type 2 diabetes in older adults. The American Diabetes Association's Standards of Care include GLP-1 receptor agonists as a preferred second-line therapy for T2D, particularly in patients with established cardiovascular disease or at high cardiovascular risk.

If you have diabetes, you likely already qualify for insurance or Medicare coverage. Start there.

Source: American Diabetes Association Standards of Care (2025).

GLP-1 and Heart Disease

I've mentioned the SELECT trial several times because it's that important. In adults 45 and older with obesity, overweight, and established cardiovascular disease (but no diabetes), semaglutide reduced major adverse cardiovascular events (MACE) — a composite of cardiovascular death, non-fatal heart attack, and non-fatal stroke — by 20%. Risk reductions were consistent across different ages, sexes, and ethnicities. The mean follow-up was nearly 40 months — this isn't short-term data.

For seniors with heart disease, GLP-1 medication may be protective, not just a weight-loss tool.

Source: Lincoff AM et al., NEJM 2023; ACC SELECT trial summary; Cleveland Clinic SELECT trial press release (2023).

GLP-1 and Joint Pain

This is the benefit seniors report most passionately. Every pound of body weight puts roughly 4 pounds of pressure on your knees. Losing 30 pounds takes 120 pounds of force off your joints. Many seniors on GLP-1 therapy report meaningful improvements in mobility — walking farther, climbing stairs with less pain, and in some cases, delaying or avoiding joint replacement surgery.

GLP-1 and Kidney Function

Early data from the FLOW trial (semaglutide) suggests kidney-protective effects in patients with type 2 diabetes and chronic kidney disease. For seniors with compromised kidney function, dosing adjustments may be necessary — your provider should check your eGFR (estimated glomerular filtration rate) before starting treatment and monitor it periodically.

Source: FLOW trial data; FDA prescribing information regarding renal impairment.

GLP-1 and Bone Health

This is an area of active research and one where the data isn't fully settled. The Wegovy prescribing information notes that in the cardiovascular outcomes trial, patients 75 and older reported more hip and pelvis fractures on Wegovy than placebo. Weight loss of any kind can affect bone density, and seniors are already at higher osteoporosis risk.

Source: Wegovy FDA prescribing information (2024 revision), geriatric use and fracture data.

How We Evaluated GLP-1 Programs for Seniors

I want you to know exactly how I made these rankings — because trust is the entire point.

What we evaluated (weighted for seniors):

What we checked: Provider websites, pricing pages, terms of service, pharmacy partner credentials, patient reviews on Trustpilot and ConsumerAffairs, and clinical team disclosures.

What we did NOT do: We did not receive free product or preferential treatment from any provider. Our rankings reflect independent evaluation. We earn a commission if you sign up through our links, but a provider's affiliate relationship does not influence where they appear in our rankings — their performance on the criteria above does.

Our verification process: We re-check pricing and policies regularly and update "Last Verified" dates accordingly. When a claim comes from the provider's own website, we label it "provider-stated." When we can independently confirm it, we say "verified." Read our full methodology.

Edge Cases: The Questions That Send Seniors Back to Search

These are the specific scenarios that cause people to leave a page and keep searching. I'd rather answer them here.

"I'm on Medicare Advantage — Is That Different from Part D?"

Yes, and it can work in your favor. Many Medicare Advantage plans include Part D drug coverage and may offer additional supplemental benefits that original Medicare doesn't. Some MA plans have already begun covering GLP-1s for qualifying diagnoses (diabetes, cardiovascular risk) with more favorable copays than standalone Part D plans. Check your specific plan's formulary, or call the number on your Medicare Advantage card and ask: "Do you cover semaglutide or tirzepatide, and under what diagnoses?"

When the BALANCE model launches for Part D plans in January 2027, Medicare Advantage Prescription Drug Plans will also have the option to participate. A separate Medicare GLP-1 Payment Demonstration is expected to begin in July 2026 as a bridge. But coverage details may vary by plan and region.

"I Travel or Snowbird — Can I Get Refills in Another State?"

Telehealth programs like MEDVi operate in most U.S. states, but licensing rules vary. Before you leave for the winter, confirm with your provider that they can prescribe and ship to your destination state. Brand-name prescriptions from your local doctor can typically be filled at any pharmacy nationwide.

For injectable medications, plan your travel around your supply. Most GLP-1 injections are weekly, so make sure you have enough pens for your trip plus a buffer. Carry medications in a cooler bag during travel, and never store them in a hot car.

"What If I Miss a Dose?"

Missed-dose rules differ by medication — don't assume one rule fits all:

Wegovy/Ozempic (semaglutide) injection: If you miss a dose and there are at least 2 days (48 hours) until your next scheduled dose, take it as soon as you remember. If fewer than 2 days remain, skip it and resume your normal schedule. Don't double up. (Source: Wegovy FDA prescribing information)

Zepbound/Mounjaro (tirzepatide) injection: Take your missed dose as soon as possible within 4 days (96 hours) of the missed dose. If more than 4 days have passed, skip it and take your next dose on the regularly scheduled day. (Source: Zepbound prescribing information, Eli Lilly)

Daily oral medications (Rybelsus, Wegovy tablets): Skip it and take the next one at your regular time the following day.

Missing an occasional dose isn't a crisis. Missing multiple weeks is more concerning — talk to your provider about whether you need to re-titrate from a lower dose.

"Can I Switch from Semaglutide to Tirzepatide (or Vice Versa)?"

Yes, with your provider's guidance. Switching isn't uncommon — some patients respond better to one than the other. Your provider will determine the appropriate starting dose for the new medication. There's usually no washout period needed, but don't manage this switch on your own. Read more: Semaglutide vs tirzepatide.

"Do I Need to Stop GLP-1 Before Surgery?"

Updated guidance (October 2024): Most patients can continue GLP-1 medications before elective surgery, according to multi-society clinical practice guidance from the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, and others.

However, if you're early in dose escalation, experiencing significant GI symptoms (nausea, vomiting, abdominal pain), or have other risk factors for delayed gastric emptying, your anesthesiology team may recommend adjustments — such as a liquid-only diet for 24 hours before the procedure or modifications to the anesthesia plan. In rare cases, the procedure may need to be delayed.

The key takeaway for seniors: Always inform your surgeon and anesthesiologist that you're on a GLP-1 medication. Work with your care team to determine the right approach for your specific situation rather than automatically stopping the medication.

Source: Multi-Society Clinical Practice Guidance, ASA et al. (October 29, 2024); published in Clinical Gastroenterology and Hepatology.

"What About Constipation?"

Constipation is one of the most common side effects and it can be particularly uncomfortable for seniors. Start with the basics: adequate water (6–8 glasses daily), dietary fiber (fruits, vegetables, whole grains), and daily movement (even a 15-minute walk helps). Stool softeners like docusate sodium are generally safe. If constipation becomes severe or persistent, tell your provider — dose adjustment may help.

"What Happens to My Cost After the Introductory Pricing?"

This catches people off guard, so I want to be transparent. MEDVi's first month is $179, but refills are $299/month. That's a $120/month increase. Budget for the refill price, not the intro price. On the brand-name side, manufacturer savings cards have expiration dates and eligibility rules. Always ask: "What will I pay in month 3, month 6, and month 12?" before you start any program.

Shots vs. Pills: A Quick Comparison for Seniors

If you can handle a weekly injection — and most people can, the needle is tiny — the injectable versions currently offer stronger weight-loss results and more flexible timing. But if needles are a hard no, oral GLP-1 is a legitimate, FDA-approved alternative that didn't exist a few years ago. Don't let the injection requirement stop you from getting treatment you need.

Frequently Asked Questions: GLP-1 for Seniors

Your Next Step

If you've read this far, you've done more research than most people do before starting any medication. That's exactly the right approach for a health decision like this.

What to Bring to Your Doctor's Appointment

Whether you're starting with your primary care doctor or a telehealth provider, walking in prepared saves time and gets you better care. Print this list or screenshot it:

Before your appointment, have ready:

• A complete list of every medication you currently take (including dosages, over-the-counter meds, and supplements)
• Your most recent lab work (A1C, kidney function, lipid panel, thyroid) — if it's from the past 6 months, most providers can work with it
• Your current weight and height (for BMI calculation — use our BMI calculator)
• A list of your diagnosed health conditions (diabetes, heart disease, high blood pressure, sleep apnea, kidney disease, etc.)
• Any history of pancreatitis, thyroid cancer, or eating disorders

Questions to ask your provider:

1. "Based on my medications, are there any drug interactions I should know about with GLP-1 therapy?"
2. "Do I need any lab work before starting?"
3. "How will we monitor my muscle mass and bone health while I'm losing weight?"
4. "What's my protein target, and can you refer me to a dietitian?"
5. "If I'm on blood pressure medication, how often should we check whether I need a dose adjustment?"
6. "What's the plan if I don't respond well to this medication?"
7. "How do I reach you if I have side effects between appointments?"

This isn't just a checklist — it's a filter. A provider who takes these questions seriously is a provider who understands what senior patients need. A provider who brushes them off? Keep looking.

This isn't about chasing a number on a scale. It's about your knees. Your heart. Your energy. Your independence. The clinical evidence says GLP-1 therapy can meaningfully improve all of these for seniors with obesity — and you have more options to access it affordably than ever before.

About Our Senior GLP-1 Eligibility Quiz

We built a free 60-second screening tool specifically for adults over 60. It asks about your age, approximate BMI, current health conditions, medications, and insurance situation. Based on your answers, it suggests the most appropriate next step — whether that's talking to your doctor about brand-name coverage, exploring a telehealth provider, or having a conversation with a specialist first.

It's not a medical evaluation. It's a starting point that helps you figure out which door to walk through. No email required, no sales pitch — just a personalized recommendation based on your situation. We designed it because the most common question we get is "where do I even start?" This answers that question in under a minute.

Last Updated: February 2026 | Last Verified (pricing and policies): February 2026